Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy

Ulcerative colitis (UC) is an inflammatory bowel disease, and intestinal bacteria are implicated in the pathogenesis of this disorder. The administration of aminosalicylates (5-ASA) is a conventional treatment that targets the mucosa, while fecal microbial transplantation (FMT) is a novel treatment...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Dagmar Schierová, Jan Březina, Jakub Mrázek, Kateřina Olša Fliegerová, Simona Kvasnová, Lukáš Bajer, Pavel Drastich
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Subjects:	ulcerative colitis microbiome fecal microbiome transplantation 5-ASA
Online Access:	https://www.mdpi.com/2073-4409/9/10/2283